Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Advantan
Active Ingredient: Methylprednisolone aceponate 0.1%w/w
Dosage Form: Topical cream
New Zealand Sponsor: LEO Pharma Limited
Manufacturer: Leo Pharma Manufacturing Srl, Milano, Italy
   
Product: Advantan
Active Ingredient: Methylprednisolone aceponate 0.1%w/w
Dosage Form: Topical ointment
New Zealand Sponsor: LEO Pharma Limited
Manufacturer: Leo Pharma Manufacturing Srl, Milano, Italy
   
Product: Clexane
Active Ingredient: Enoxaparin sodium 100mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Sanofi Winthrop Industrie, Le Trait, France
Sanofi Winthrop Industrie, Maisons-Alfort, France
Genzyme Biosurgery A Division of Genzyme Corporation, New Jersey, United States of America
   
Product: Dolomed Ibuprofen Liquicaps (General sale)
Active Ingredient: Ibuprofen 200mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: AdiraMedica Pty Limited
Manufacturer: Softgel Healthcare Pvt. Limited, Pudupakkam Village, India
   
Product: Dolomed Ibuprofen Liquicaps (Pharmacy only)
Active Ingredient: Ibuprofen 200mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: AdiraMedica Pty Limited
Manufacturer: Softgel Healthcare Pvt. Limited, Pudupakkam Village, India
   
Product: Dolomed Ibuprofen Liquicaps
Active Ingredient: Ibuprofen 400mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: AdiraMedica Pty Limited
Manufacturer: Softgel Healthcare Pvt. Limited, Pudupakkam Village, India


Dated this 13th day of May 2024.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).